(Press-News.org) Previously, the primary endpoint results of the NRG-LU005 study assessing the addition of the immunotherapy drug atezolizumab to standard of care concurrent chemoradiation for limited-state small cell lung cancer was reported at the American Society for Radiation Oncology 2024 Annual Meeting. Those results showed that adding atezolizumab did not improve overall survival (OS) for this patient population. At the same time, an exploratory analysis reported longer median OS among patients who received twice-a-day radiation, though RT schedule was not randomized. As a follow up to that study, a patient-reported outcomes (PRO) analysis explored the impact of the NRG-LU005 treatment regimens on quality of life (QOL). The results of this PRO analysis were recently reported as a late-breaking abstract at the ASTRO 2025 Annual Meeting in San Francisco, California.
Although NRG-LU005 results did not meet its primary endpoint regarding OS, the study reported that twice daily radiation was associated with better survival than once daily radiation. While this study was not randomized between twice-daily and once-daily radiation, the NRG-LU005 PRO analysis also suggested less clinically meaning decline in longer term QOL with twice daily (versus once daily) radiation.
NRG-LU005 accrued 544 evaluable patients and randomized patients receiving standard chemoradiation with thoracic RT (either at 45Gy twice daily or 66Gy daily) to plus/minus concurrent and adjuvant immunotherapy PROs included validated instruments: FACT-TOI, EQ-5D-5L, and PROMIS-Fatigue. Clinical meaningful decline (CMD) and longitudinal trends were also evaluated.
PRO compliance for this analysis exceeded 85% at baseline and stabilized at 60-68% through 21 months after completion of chemoradiation. Higher completion correlated with better baseline performance status and pulmonary function. FACT-TOI declined on both arms during chemoradiation as expected; however, this improved at 3 months and either remained stable or exceeded the baseline by 6-21 months following treatment. As hypothesized, fewer patients on the immunotherapy arm of NRG-LU005 experienced CMD (25% vs. 38%) in FACT-TOI at 21 months. Of note, while this study was not randomized between twice daily and once daily RT, approximately half of the patients received twice daily radiation, and this was associated with relatively better quality of life (QOL) over time than those receiving once daily radiation in the analysis. This overall benefit in QOL on the twice-daily RT arm was further supported by a multivariable analysis.
“While this study was not randomized between twice-daily versus once-daily radiation, these QOL findings suggest that, relative to once-daily radiation, twice-daily radiation is associated with quality-of-life advantages from the patient perspective,” says Dr. Benjamin Movsas, QOL chair of this NRG LU005 study as well as Medical Director of Henry Ford Cancer in Michigan
Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under Award Number U10CA180868 (NRG Oncology Operations), U10CA180822 (NRG Oncology SDMC), UG1CA189867 (NCORP), U24CA196067 (NRG Specimen Bank), U24CA180803 (IROC), CTEP. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This project was also supported by Genentech.
Special Podcast Episode
Follow The NRG Oncology Podcast on Spotify, Apple Podcasts, and YouTube for a special episode interviewing Dr. Benjamin Movsas on the findings of the 2025 ASTRO Late-Breaking Session Presentation for NRG-LU005. Podcast information and playable episodes are available on the NRG website as well.
Citation
Movsas B, Hu C, Higgins KA, Ross HJ, Jabbour SK, Kozono DE, Owonikoko TK, Xiao C, Shoji T, Faller BA, Mohindra P, Dib EG, Brownstein JM, Chun SG, Kuzma CS, Kotecha RR, Onitilo AA, Paulus R, Bradley JD, Bruner DW. Comprehensive Patient Reported Outcomes (PROs) from NRG LU005: A Randomized Trial Of Chemoradiation (CRT) +/- Atezolizumab In Limited-Stage Small Cell Lung Cancer (LS-SCLC). Paper presented during the Late Breaking Abstract Session at the annual meeting of the American Society for Radiation Oncology. San Francisco, CA. (2025, September-October).
About NRG Oncology
NRG Oncology conducts practice-changing, multi-institutional clinical and translational research to improve the lives of patients with cancer. Founded in 2012, NRG Oncology is a Pennsylvania-based nonprofit corporation that integrates the research of the legacy National Surgical Adjuvant Breast and Bowel Project (NSABP), Radiation Therapy Oncology Group (RTOG), and Gynecologic Oncology Group (GOG) programs. The research network seeks to carry out clinical trials with emphasis on sex-specific malignancies, including gynecologic, breast, and prostate cancers, and on localized or locally advanced cancers of all types. NRG Oncology’s extensive research organization comprises multidisciplinary investigators, including medical oncologists, radiation oncologists, surgeons, physicists, pathologists, and statisticians, and encompasses more than 1,300 research sites located world-wide with predominance in the United States and Canada. NRG Oncology is supported primarily through grants from the National Cancer Institute (NCI) and is one of five research groups in the NCI’s National Clinical Trials Network. www.nrgoncology.org
END
Patient-reported outcome analysis of NRG Oncology trial in limited-stage small cell lung cancer suggests quality of life benefit with twice - (vs once -) daily radiation
2025-09-30
ELSE PRESS RELEASES FROM THIS DATE:
NRG Oncology trial analysis shows improvement in survival outcomes for glioblastoma patients receiving proton therapy, trial moves to phase III
2025-09-30
Previously, results from the photon cohort of the NRG-BN001, a signal seeking Phase II randomized trial, indicated that photon radiation dose intensification (75 Gy) did not demonstrate improvement in overall survival (OS) for patients with newly diagnosed glioblastoma (GBM). The recent analysis of the proton cohort revealed improved survival for patients receiving proton therapy at 75 Gy. Because this data met the pre-defined survival improvement threshold, they could be used to design and conduct a definitive phase III randomized ...
In a landmark move, ECMWF is poised to announce a new phase in its data sharing strategy
2025-09-30
As part of its strategy and ongoing commitment to open science, ECMWF (The European Centre for Medium-Range Weather Forecasts) has been opening its extensive data catalogue and making its science more widely open and accessible.
The organisation holds one of the world’s largest meteorological archives, exceeding 1.3 exabytes of data. Starting with historical data and charts, and ECMWF is now moving to make real-time forecast data openly available. By making its data openly available, ECMWF is supporting the UN’s Early Warnings for All initiative and enabling societies ...
Seal’s sensitive whiskers hold key to foiling fish escapes
2025-09-30
Life beneath the waves can be a game of cat and mouse. Seals pursue swimming fish by following the tell-tale wakes and spinning vortices they leave behind, sensing the faint swirls with their sensitive whiskers. But fish might have a trick up their sleeves. Yvonne Krüger from University of Rostock, Germany, explains that escaping fish produce three jets of different sizes they dart away, squirting in individual directions almost simultaneously – at least two of which form into vortex rings, like smoke rings – which could confuse a seal. But might seals be able to see through the ...
Neurological outcomes after patients suffer cardiac arrest at home are similar between low- and high-income areas in Vienna
2025-09-30
Vienna, Austria: People who have a cardiac arrest in their own homes have similar neurological outcomes regardless of socioeconomic background, according to research presented at the European Emergency Medicine Congress today (Wednesday) [1].
However, the study of 676 patients who received treatment in the Department of Emergency Medicine at the Medical University of Vienna suggested that those who lived in lower-income areas may be less likely to receive cardiopulmonary resuscitation (CPR) from bystanders compared to people suffering a cardiac arrest (when the heart stops pumping blood around the body) in higher-income areas – a finding ...
Precision without incision: the new era of functional radiosurgery
2025-09-30
MIAMI, FLORIDA (Sept. 30, 2025) -- Research findings from Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, are being presented this week at ASTRO 2025 – the American Society for Radiation Oncology’s annual meeting in San Francisco.
Markus Bredel, M.D., Ph.D., professor and chair of the Miller School’s Department of Radiation Oncology, presented at the Presidential Symposium, focusing on “Precision Without Incision: The New Era of Functional Radiosurgery.” His session, “Classical Movement Disorders and Connectomics: Image-Guided ...
University of Miami scientists launch accessible global climate modeling framework
2025-09-30
University of Miami scientists launch accessible global climate modeling framework
Designed for education, adaptable for research—the new Python-based framework makes climate dynamics more approachable for students and researchers
Miami, FL — A team of researchers at the University of Miami has developed a global atmospheric modeling framework that blends powerful research capabilities with accessibility for students and scientists alike. Written entirely in Python, a high-level, general-purpose programming language, and designed to run on an interactive Jupyter Notebook, the ...
Parallel atom-photon entanglement paves way for future quantum networking
2025-09-30
A new platform developed by Illinois Grainger engineers demonstrates the utility of a ytterbium-171 atom array in quantum networking. Their work represents a key step toward long distance quantum communication.
A new platform developed by Illinois Grainger engineers demonstrates the utility of a ytterbium-171 atom array in quantum networking. Their work represents a key step toward long distance quantum communication.
Researchers from The Grainger College of Engineering at the University of Illinois Urbana-Champaign have introduced a scalable platform for quantum networking with a ytterbium-171 ...
Single-step battery cathode recycling
2025-09-30
A new battery recycling method developed by Illinois Grainger engineers removes scarce, expensive metals from old battery cathodes and coats them onto new cathodes in a single step. The result is significantly more affordable, less environmentally impactful and less risky to health than any recycling method currently in use.
Battery cathodes – the positive part of the battery that helps to store electrical energy – often require rare, expensive metals such as cobalt. It is therefore crucial to develop effective means for recycling cathodes that reclaim the metals essential to their operation.
Researchers in The Grainger College of Engineering at the University of Illinois ...
Farm conservation is an economical path to save Colorado River water
2025-09-30
The most cost-effective way to conserve the dwindling waters of the Colorado River may not come from building new reservoirs, canals, or wells, but from changing how water is used on farms that consume most of it.
That’s the conclusion of a comprehensive study by UC Riverside’s School of Public Policy, conducted with the Utah Rivers Council.
Led by UCR graduate student Paloma Avila, the study examined 462 federally funded Colorado River conservation and supply projects, totaling about $1 billion (in 2023 constant dollars) between 2004 and 2024, using available spending data from the U.S. Bureau of Reclamation.
It ...
Feeling in control helps beat daily stress, researchers find
2025-09-30
UNIVERSITY PARK, Pa. — A looming deadline at work, a clogged toilet, an argument with a loved one — these daily hassles can make any day feel more stressful. When these demands pile up, it can feel overwhelming, like there’s no end in sight. Yet, the perception of control could make resolving these everyday inconveniences easier, according to a new study from a team including researchers from Penn State.
The research team found that on days when people felt they had more control over stressors ...